{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:24:26Z","timestamp":1790713466290,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["UL1 RR025780"],"award-info":[{"award-number":["UL1 RR025780"]}]},{"name":"NIH","award":["UL1 TR001082, N01-HV-48194"],"award-info":[{"award-number":["UL1 TR001082, N01-HV-48194"]}]},{"name":"NIH","award":["R01 HL69071"],"award-info":[{"award-number":["R01 HL69071"]}]},{"name":"NIH","award":["R01 HL 116906"],"award-info":[{"award-number":["R01 HL 116906"]}]},{"name":"NIH","award":["K23 JL067915"],"award-info":[{"award-number":["K23 JL067915"]}]},{"name":"NIH","award":["R01HL109209"],"award-info":[{"award-number":["R01HL109209"]}]},{"name":"CRTrieste Foundation"},{"DOI":"10.13039\/501100009699","name":"GENERALI Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009699","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ppc-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Pediatric Cardiology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ppedcard.2014.10.003","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T16:37:12Z","timestamp":1413995832000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Genetic causes of dilated cardiomyopathy"],"prefix":"10.1016","volume":"37","author":[{"given":"Luisa","family":"Mestroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Spezzacatene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.G.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ppedcard.2014.10.003_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/euhj.1998.1145","article-title":"Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy","volume":"20","author":"Mestroni","year":"1999","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ppedcard.2014.10.003_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.ppedcard.2014.10.003_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.7326\/0003-4819-117-2-117","article-title":"The clinical course of idiopathic dilated cardiomyopathy. A population-based study","volume":"117","author":"Sugrue","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0020","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.296.15.1867","article-title":"Incidence, causes, and outcomes of dilated cardiomyopathy in children","volume":"296","author":"Towbin","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/oxfordjournals.eurheartj.a015092","article-title":"Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies","volume":"18","author":"Rakar","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0035","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa021715","article-title":"The incidence of pediatric cardiomyopathy in two regions of the United States","volume":"348","author":"Lipschultz","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ppedcard.2014.10.003_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ppedcard.2007.08.013","article-title":"Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy","volume":"24","author":"Cox","year":"2007","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-5223(99)70431-9","article-title":"Excellent long-term functional outcome after an operation for anomalous left coronary artery from the pulmonary artery","volume":"117","author":"Cochrane","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.jacc.2009.02.014","article-title":"Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia","volume":"53","author":"Medi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/hrt.2007.119792","article-title":"Hypocalcemia and vitamin D deficiency: an important, but preventable cause of life-threatening infant heart failure","volume":"94","author":"Maiya","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0065","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/01.CIR.62.5.1054","article-title":"Echocardiographic measurements in normal subjects from infancy to old age","volume":"62","author":"Henry","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0735-1097(99)00172-2","article-title":"Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity","volume":"34","author":"Mestroni","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals","volume":"12","author":"Hershberger","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s000590050003","article-title":"The \u201cFinal Common Pathway\u201d hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy","volume":"25","author":"Bowles","year":"2000","journal-title":"Herz"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0085","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2010.11.061","article-title":"Arrhythmias and dilated cardiomyopathy common pathogenetic pathways?","volume":"57","author":"Towbin","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0090","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0095","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","article-title":"Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy","volume":"343","author":"Kamisago","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","article-title":"Genetic testing for dilated cardiomyopathy in clinical practice","volume":"18","author":"Lakdawala","year":"2012","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12265-010-9188-4","article-title":"Sarcomere gene mutations in hypertrophy and heart failure","volume":"3","author":"Morita","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCGENETICS.112.962761","article-title":"Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy","volume":"5","author":"Lakdawala","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"issue":"54","key":"10.1016\/j.ppedcard.2014.10.003_bb0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jacc.2009.04.029","article-title":"Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?","volume":"21","author":"Mestroni","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.104.507699","article-title":"\u03b1-Myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy","volume":"112","author":"Carniel","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-291X(02)02374-4","article-title":"Novel mutations in sarcomeric protein genes in dilated cardiomyopathy","volume":"298","author":"Daehmlow","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0130","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1073\/pnas.93.17.8999","article-title":"Alteration of myosin cross bridges by phosphorylation of myosin-binding-protein C in cardiac muscle","volume":"93","author":"Weisberg","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10741-005-5252-6","article-title":"Sarcomeric protein mutations in dilated cardiomyopathy","volume":"10","author":"Chang","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N Engl J Med"},{"issue":"7389","key":"10.1016\/j.ppedcard.2014.10.003_bb0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/483281a","article-title":"Genetics: broken giant linked to heart failure","volume":"483","author":"McNally","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0150","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cts.12116","article-title":"Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy","volume":"6","author":"Merlo","year":"2013","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.hco.0000221575.33501.58","article-title":"Lamin A\/C and cardiac disease","volume":"21","author":"Sylvius","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0160","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0735-1097(02)01724-2","article-title":"Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin a\/C defect-related disease","volume":"39","author":"Arbustini","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/humu.20250","article-title":"Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy","volume":"26","author":"Taylor","year":"2005","journal-title":"Hum Mutat"},{"issue":"15","key":"10.1016\/j.ppedcard.2014.10.003_bb0180","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"issue":"5611","key":"10.1016\/j.ppedcard.2014.10.003_bb0190","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0195","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ppedcard.2014.10.003_bb0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.106.646778","article-title":"Prevalence of desmin mutations in dilated cardiomyopathy","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0210","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","article-title":"Mutations in Cypher\/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction","volume":"42","author":"Vatta","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0215","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1074\/jbc.M311849200","article-title":"A Cypher\/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C","volume":"279","author":"Arimura","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.20376","article-title":"Mutations in ZASP define a novel form of muscular dystrophy in humans","volume":"57","author":"Selcen","year":"2005","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ppedcard.2014.10.003_bb0225","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X\u2011linked dilated cardiomyopathy: molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0230","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/humu.21603","article-title":"Dilated cardiomyopathy-associated BAG3 mutations impair Z-disc assembly and enhance sensitivity to apoptosis in cardiomyocytes","volume":"32","author":"Arimura","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2011.01.016","article-title":"Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy","volume":"88","author":"Norton","year":"2011","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.ppedcard.2014.10.003_bb0240","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/jcp.24615","article-title":"Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathy","volume":"229","author":"Feldman","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.107.689984","article-title":"Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells","volume":"116","author":"Kn\u00f6ll","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0250","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.20973","article-title":"Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness","volume":"60","author":"Murakami","year":"2006","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.ppedcard.2014.10.003_bb0255","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/eurjhf\/hfq093","article-title":"Prognostic impact of familial screening in dilated cardiomyopathy","volume":"12","author":"Moretti","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"7497","key":"10.1016\/j.ppedcard.2014.10.003_bb0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature13127","article-title":"Guidelines for investigating causality of sequence variants in human disease","volume":"508","author":"MacArthur","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/HCO.0b013e32835fb728","article-title":"Genetic testing in cardiovascular medicine: current landscape and future horizons","volume":"28","author":"Sturm","year":"2013","journal-title":"Curr Opin Cardiol"},{"issue":"4","key":"10.1016\/j.ppedcard.2014.10.003_bb0270","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCGENETICS.112.962928","article-title":"Population-based variation in cardiomyopathy genes","volume":"5","author":"Golbus","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0275","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1152\/physrev.00012.2002","article-title":"Molecular mechanisms of inherited cardiomyopathies","volume":"82","author":"Fatkin","year":"2002","journal-title":"Physiol Rev"},{"issue":"14","key":"10.1016\/j.ppedcard.2014.10.003_bb0280","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/CIRCULATIONAHA.109.192064","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0285","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008","volume":"8","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0290","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0295","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ppedcard.2014.10.003_bb0300","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0305","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0310","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure. Metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF)","volume":"353","author":"MERIT-HF Study Group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0315","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0320","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effects of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinic outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomized controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0330","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1161\/CIRCULATIONAHA.109.192065","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults","volume":"119","author":"Hunt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0335","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0340","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0350","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(03)13501-5","article-title":"Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study","volume":"361","author":"Jong","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1388-9842(00)00080-5","article-title":"Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT","volume":"2","author":"Thackray","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ppedcard.2014.10.003_bb0365","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCEP.111.962050","article-title":"Arrhythmogenic disorders of genetic origin. Dilated cardiomyopathy","volume":"6","author":"Lakdawala","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9791","key":"10.1016\/j.ppedcard.2014.10.003_bb0370","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ppedcard.2014.10.003_bb0375","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ppedcard.2014.10.003_bb0380","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ppedcard.2014.10.003_bb0385","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.ppedcard.2014.10.003_bb0390","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ng.2963","article-title":"RAF1 mutations in childhood-onset dilated cardiomyopathy","volume":"46","author":"Dhandapany","year":"2014","journal-title":"Nat Genet"},{"issue":"144","key":"10.1016\/j.ppedcard.2014.10.003_bb0395","doi-asserted-by":"crossref","first-page":"144ra102","DOI":"10.1126\/scitranslmed.3003875","article-title":"Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A\/C gene mutation","volume":"4","author":"Choi","year":"2012","journal-title":"Sci Transl Med"},{"issue":"144","key":"10.1016\/j.ppedcard.2014.10.003_bb0400","doi-asserted-by":"crossref","first-page":"144ra103","DOI":"10.1126\/scitranslmed.3003802","article-title":"Rapamycin reverses elevated mTORC1 signaling in lamin A\/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival","volume":"4","author":"Ramos","year":"2012","journal-title":"Sci Transl Med"}],"container-title":["Progress in Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981314000162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981314000162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T12:21:35Z","timestamp":1650457295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1058981314000162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1058981314000162"],"URL":"https:\/\/doi.org\/10.1016\/j.ppedcard.2014.10.003","relation":{},"ISSN":["1058-9813"],"issn-type":[{"value":"1058-9813","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic causes of dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Progress in Pediatric Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ppedcard.2014.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}